← Back to Patent Explorer
US4543257A Expired / Lapsed US ⏱️ 0.0 years remaining

1-Carba-2-penem-3-carboxylic acid

Assignee: Merck and Co Inc
•
Filing: 1980-01-04
•
Granted: 1985-09-24
•
Expires: 2000-01-04
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Disclosed are 1-carba-2-penem-3-carboxylic acids of the following structure: <IMAGE> wherein R1, R2 and R3 are, inter alia, independently selected from the group consisting of hydrogen, alkyl, aryl, and aralkyl. Such compounds as well as their pharmaceutically acceptable salt, ester and amide derivatives are useful as antibiotics. Also disclosed are processes for the preparation of such compounds, pharmaceutical compositions comprising such compounds and methods of treatment comprising administering such compounds and compositions when an antibiotic effect is indicated.

Inventors

  • 👤 Lovji D. Cama
  • 👤 Burton G. Christensen

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 23:42
CPC Classifications
C; C07; C07D; C07D205/00; C07D205/02; C07D205/06; C07D205/08; C07D477/00; C07D477/10; C07F; C07F7/00; C07F7/02; C07F7/08; C07F7/18; C07F7/1804; C07F9/00; C07F9/02; C07F9/547; C07F9/553; C07F9/568

Claims Analysis

Total Claims: 44
Claim 1
Independent Claim 156 words
A compound having the structural formula: ##STR590## and the pharmaceutically acceptable salts thereof wherein R 1 , R 2 and R 3 are independently selected from the group consisting of: hydrogen, mono-substituted and unsubstituted: alkyl having from 1 to 10 carbon atoms, alkenyl and akynyl having from 2 to 10 carbon atoms, cycloalkyl, cycloalkylalkyl, cycloalkylalkenyl and cycloalkenylalkyl wherein the preceding cycloalkyl or cycloalkenyl moieties comprise 3 to 6 carbon atoms and the alkyl or alkenyl moieties comprise 1 to 6 carbon atoms, phenyl, phenylalkyl, phenylalkenyl and phenylalkynyl having 1-6 carbon atoms in the chain; and wherein the substituent relative to the above-listed groups is selected from the group consisting of amino, hydroxyl, mercapto, alkylthio having from 1 to 6 carbon atoms, sulfamoyl, amidino, guanidino, nitro, chloro, bromo, fluoro, cyano, and carboxyl; with the proviso that when one of R 1 or R 2 is hydrogen and the other is 1-hydroxyethyl, then R 3 is not hydrogen.
Claim 2
Dependent Claim 156 words
A compound having the structural formula: ##STR590## and the pharmaceutically acceptable salts thereof wherein R 1 , R 2 and R 3 are independently selected from the group consisting of: hydrogen, mono-substituted and unsubstituted: alkyl having from 1 to 10 carbon atoms, alkenyl and akynyl having from 2 to 10 carbon atoms, cycloalkyl, cycloalkylalkyl, cycloalkylalkenyl and cycloalkenylalkyl wherein the preceding cycloalkyl or cycloalkenyl moieties comprise 3 to 6 carbon atoms and the alkyl or alkenyl moieties comprise 1 to 6 carbon atoms, phenyl, phenylalkyl, phenylalkenyl and phenylalkynyl having 1-6 carbon atoms in the chain; and wherein the substituent relative to the above-listed groups is selected from the group consisting of amino, hydroxyl, mercapto, alkylthio having from 1 to 6 carbon atoms, sulfamoyl, amidino, guanidino, nitro, chloro, bromo, fluoro, cyano, and carboxyl; with the proviso that when one of R 1 or R 2 is hydrogen and the other is 1-hydroxyethyl, then R 3 is not hydrogen.
Claim 3
Dependent Claim 112 words
A compound according to claim 1 wherein R 2 is hydrogen and R 1 and R 3 are independently selected from the group consisting of hydrogen (R 3 is not hydrogen), mono-substituted or unsubstituted: alkyl having from 1 to 6 carbon atoms, aralkyl wherein the aryl moiety is phenyl and the alkyl moiety contains 1 to 6 carbon atoms, aralkyl wherein the aryl moiety is phenyl and the alkyl moiety contains 1 to 6 carbon atoms, aralkenyl wherein the aryl moiety is phenyl and the alkenyl moiety contains 2 to 6 carbon atoms, and phenyl; wherein the substituent is selected from the group consisting of hydroxyl, amino, chloro, bromo, fluoro and carboxyl.
Claim 4
Dependent Claim 20 words
A compound according to claim 2 having the structure: ##STR591## wherein n is an integer selected from 1 to 4.
Claim 5
Dependent Claim 35 words
A compound having the structural formula: ##STR592## and the pharmaceutically acceptable salts thereof wherein R 2 is selected from the group consisting of: ##STR593## and R 3 is selected from the group consisting of: ##STR594##
Claim 6
Dependent Claim 35 words
A compound having the structural formula: ##STR592## and the pharmaceutically acceptable salts thereof wherein R 2 is selected from the group consisting of: ##STR593## and R 3 is selected from the group consisting of: ##STR594##
Claim 7
Dependent Claim 11 words
A compound according to claim 4 wherein R 2 is ##STR595##
Claim 8
Dependent Claim 11 words
A compound according to claim 4 wherein R 2 is ##STR596##
Claim 9
Dependent Claim 11 words
A compound according to claim 4 wherein R 2 is ##STR597##
Claim 10
Dependent Claim 11 words
A compound according to claim 4 wherein R 2 is ##STR598##
Claim 11
Dependent Claim 11 words
A compound according to claim 4 wherein R 2 is ##STR599##
Claim 12
Dependent Claim 11 words
A compound according to claim 4 wherein R 2 is ##STR600##
Claim 13
Dependent Claim 11 words
A compound according to claim 4 wherein R 2 is ##STR601##
Claim 14
Dependent Claim 11 words
A compound according to claim 4 wherein R 2 is ##STR602##
Claim 15
Dependent Claim 11 words
A compound according to claim 4 wherein R 2 is ##STR603##
Claim 16
Dependent Claim 11 words
A compound according to claim 4 wherein R 2 is ##STR604##
Claim 17
Dependent Claim 11 words
A compound according to claim 4 wherein R 2 is ##STR605##
Claim 18
Dependent Claim 11 words
A compound according to claim 4 wherein R 2 is ##STR606##
Claim 19
Dependent Claim 20 words
A compound according to claim 4 wherein R 2 is ##STR607## and R 3 is --C.tbd.C--CH 2 NH 2 .
Claim 20
Dependent Claim 18 words
A compound according to claim 4 wherein R 2 is --CH 2 OH and R 3 is ##STR608##
Claim 21
Dependent Claim 18 words
A compound according to claim 4 wherein R 2 is --CH 2 OH and R 3 is ##STR609##
Claim 22
Dependent Claim 18 words
A compound according to claim 4 wherein R 2 is --CH 2 OH and R 3 is ##STR610##
Claim 23
Dependent Claim 18 words
A compound according to claim 4 wherein R 2 is --CH 2 OH and R 3 is ##STR611##
Claim 24
Dependent Claim 18 words
A compound according to claim 4 wherein R 2 is --CH 2 OH and R 3 is ##STR612##
Claim 25
Dependent Claim 18 words
A compound according to claim 4 wherein R 2 is --CH 2 OH and R 3 is ##STR613##
Claim 26
Dependent Claim 22 words
A compound according to claim 4 wherein R 2 is --CH 2 OH and R 3 is --C.tbd.C--CH 2 NH 2 .
Claim 27
Dependent Claim 11 words
A compound according to claim 4 wherein R 2 is ##STR614##
Claim 28
Dependent Claim 11 words
A compound according to claim 4 wherein R 2 is ##STR615##
Claim 29
Dependent Claim 11 words
A compound according to claim 4 wherein R 2 is ##STR616##
Claim 30
Dependent Claim 11 words
A compound according to claim 4 wherein R 2 is ##STR617##
Claim 31
Dependent Claim 11 words
A compound according to claim 4 wherein R 2 is ##STR618##
Claim 32
Dependent Claim 11 words
A compound according to claim 4 wherein R 2 is ##STR619##
Claim 33
Dependent Claim 11 words
A compound according to claim 4 wherein R 2 is ##STR620##
Claim 34
Dependent Claim 11 words
A compound according to claim 4 wherein R 2 is ##STR621##
Claim 35
Dependent Claim 11 words
A compound according to claim 4 wherein R 2 is ##STR622##
Claim 36
Dependent Claim 11 words
A compound according to claim 4 wherein R 2 is ##STR623##
Claim 37
Dependent Claim 11 words
A compound according to claim 4 wherein R 2 is ##STR624##
Claim 38
Dependent Claim 18 words
A compound according to claim 4 wherein R 2 is CF 3 CH(OH)-- and R 3 is phenyl.
Claim 39
Dependent Claim 18 words
A compound according to claim 4 wherein R 2 is CF 3 CH(OH)-- and R 3 is ##STR625##
Claim 40
Dependent Claim 18 words
A compound according to claim 4 wherein R 2 is CF 3 CH(OH)-- and R 3 is ##STR626##
Claim 41
Dependent Claim 20 words
An antibiotic composition comprising a therapeutically effective amount of a compound according to claim 1 and a pharmaceutical carrier therefor.
Claim 42
Dependent Claim 24 words
An antibiotic composition comprising, in unitary dosage form, a therapeutically effective amount of a compound according to claim 1 and a pharmaceutical carrier therefor.
Claim 43
Dependent Claim 6 words
The compound which is benzyl 7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate.
Claim 44
Dependent Claim 6 words
The compound which is benzyl 7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate.

References Cited (Backward Citations)

US4196211A Cited
US4203902A Cited
US4260627A Cited
US4267188A Cited
US4262009A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1988-09-23 1989-03-25 1989-09-24 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1992-09-23 1993-03-25 1993-09-24 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1996-09-23 1997-03-25 1997-09-24 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag